Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01404260
What this trial is testing

Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 219
Testing effectiveness (Phase 2)Study completedNCT00428896
What this trial is testing

A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital of Crete 24
Testing effectiveness (Phase 2)Ended earlyNCT01310855
What this trial is testing

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
University College, London 38
Large-scale testing (Phase 3)UnknownNCT04239833
What this trial is testing

SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd. 240
Large-scale testing (Phase 3)WithdrawnNCT03529084
What this trial is testing

Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations

Who this might be right for
Carcinoma, Non-small Cell Lung
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01196234
What this trial is testing

Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Asan Medical Center 84
Testing effectiveness (Phase 2)Study completedNCT01610336
What this trial is testing

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 161
Early research (Phase 1)Ended earlyNCT00033449
What this trial is testing

Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+5 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00127829
What this trial is testing

Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic

Who this might be right for
Tumors
AstraZeneca 66
Testing effectiveness (Phase 2)Study completedNCT00040794
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+4 more
National Cancer Institute (NCI) 144
Testing effectiveness (Phase 2)Study completedNCT00452244
What this trial is testing

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
National Cancer Center, Korea 110
Testing effectiveness (Phase 2)Study completedNCT00333294
What this trial is testing

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 50
Early research (Phase 1)Study completedNCT03050177
What this trial is testing

Bioequivalence Study of Gefitinib Tablets Under Fed Conditions

Who this might be right for
Healthy
Hunan Kelun Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00173875
What this trial is testing

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Taiwan University Hospital 108
Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Testing effectiveness (Phase 2)Ended earlyNCT00093652
What this trial is testing

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00024089
What this trial is testing

Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 60
Not applicableUnknownNCT03602027
What this trial is testing

Phase I Study of the Combination of Anlotinib With Gefitinib

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04143607
What this trial is testing

ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC

Who this might be right for
Locally Advanced or Metastatic NSCLC
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 337
Testing effectiveness (Phase 2)Study completedNCT00026299
What this trial is testing

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 14
Next Page